Chinese Journal Of Cancer Research

SCI SCIE

国际简称：CHINESE J CANCER RES 参考译名：中国癌症研究杂志

主要研究方向：医学-肿瘤学非预警期刊审稿周期：约4.5月

《中国癌症研究杂志》(Chinese Journal Of Cancer Research)是一本由Springer Berlin Heidelberg出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
66 年发文量
6.7 IF影响因子
未开放 是否OA
1988 创刊年份
Quarterly 出版周期
English 出版语言

Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.

CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.

[ 查看全部 ]

投稿咨询加急咨询

Chinese Journal Of Cancer Research期刊信息

ISSN：1000-9604
出版语言：English
是否OA：未开放
E-ISSN：1993-0631
出版地区：PEOPLES R CHINA
是否预警：否
出版商：Springer Berlin Heidelberg
出版周期：Quarterly
创刊时间：1988
开源占比：0.9886
Gold OA文章占比：100.00%
OA被引用占比：0.2974...
出版国人文章占比：0.78
出版撤稿占比：0
研究类文章占比：80.30%

Chinese Journal Of Cancer Research CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.9

1.406

1.168

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	74 / 428	82%
大类：Medicine 小类：Cancer Research	Q2	64 / 233	72%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Chinese Journal Of Cancer Research中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	1区	ONCOLOGY 肿瘤学	2区

Chinese Journal Of Cancer Research JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	58 / 333	82.7
学科：ONCOLOGY	SCIE	Q1	76 / 333	77.33

Chinese Journal Of Cancer Research历年数据统计

影响因子

中科院分区

Chinese Journal Of Cancer Research中国学者发文选摘

1、Expert consensus on multidisciplinary management of laparoscopic-endoscopic cooperative surgery combined with sentinel lymph node navigation surgery for early gastric cancer (2026 edition
Author: Zheng, Zhi; Zhao, Yu; Xu, Rui; Wang, Zimeng; Yin, Jie; Meng, Fandong; Liu, Kuiliang; Chen, Guangyong; Zhang, Jun; Li, Peng; Chen, Lin; Zhang, Zhongtao; Zhang, Shutian

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.01
2、Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort stud
Author: Zhang, Guozhi; Ren, Lin; Xiao, Jia; Bao, Yangqiu; Tian, Hao; Shi, Qiyun; Tang, Chunlin; Chen, Ping; Liang, Yan; Tang, Peng; Yan, Wenting; Zhang, Ye; Qi, Xiaowei; Guo, Yanli; Zhang, Yi

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.02
3、Circulating tumor cells with chromosome 8 aneuploidy are a diagnostic and prognostic monitoring biomarker for ovarian cance
Author: Yang, Shimin; Li, Buyun; Cheng, Hongyan; Ye, Xue; Dou, Sha; Wang, Yuanfen; Song, Xuelian; Yang, Huarui; Chang, Xiaohong; Li, Yi

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.05
4、Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathwa
Author: Wang, Zhipeng; Wang, Jie; Chen, Shuang; Wu, Ruicheng; Tuo, Zhouting; Ye, Luxia; Yoo, Koo Han; Li, Dengxiong; Jin, Xiaodong; Xiong, Wei; Feng, Dechao

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.06
5、Chemotherapy-free regimen: Real-world efficacy and safety of anlotinib plus PD-1/PD-L1 inhibitors in advanced non-small cell lung cance
Author: Chen, Haiyang; Yang, Guanghua; Wang, Tao; Chen, Gongbin; Xu, Aiguo; Ma, Chunzheng; Shang, Ke; Liu, Peijie; Zhou, Honglin; Wang, Zhiwei; Xu, Xinju; Sun, Xiao; Zhai, Fengyu; Ji, Yuanyuan; Huangfu, Juan; Jia, Xinli; Li, Chunqing; Mei, Jiazhuan; Jia, Minyong; Niu, Shunhai; Zhang, Gaogao; Liu, Yuqing; Lu, Lin; Zhang, Juntao; Wang, Lijun; Ma, Tianjiang; Gao, Liwei; Jin, Cailing; Wang, Qiming

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.03
6、Frontiers in bacterial outer membrane vesicles: From basic characteristics to cancer therap
Author: Ma, Siyang; Sun, Jianxuan; Xu, Jingyu; An, Ye; Xu, Jinzhou; Wang, Shaogang; Xia, Qidong

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2026; Vol. 38, Issue 1, pp. -. DOI: 10.21147/j.issn.1000-9604.2026.01.07
7、Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter stud
Author: Zhong, Qing; Sun, Yuqin; Lian, Mingqiao; Wang, Zengbin; Li, Baolong; Yu, Junhua; Ma, Yubin; Wu, Shichao; Wang, Yonghong; Wu, Ju; Zhu, Jiyun; Ye, Wen; Zhang, Zhiquan; Weng, Caiming; Wu, Dong; Chen, Qiuxian; Chen, Qiyue; Li, Ping; Zheng, Chaohui; Cai, Lisheng; Huang, Changming

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2025; Vol. 37, Issue 2, pp. -. DOI: 10.21147/j.issn.1000-9604.2025.02.05
8、Context-dependent roles of 5-HT and its receptors in tumor growth and wound healing: Mechanisms and therapeutic implication
Author: Zeng, Qingya; Zhu, Jiaojiao; He, Zongyun; Qin, Hong; Zhou, Wenhu; Hua, Fangqi; Yang, Jin

Journal: CHINESE JOURNAL OF CANCER RESEARCH. 2025; Vol. 37, Issue 2, pp. -. DOI: 10.21147/j.issn.1000-9604.2025.02.11